The effects of oral micronized progesterone on smoked cocaine self-administration in women

Hormones and Behavior

Volumn 59, Issue 2, 2011, Pages 227-235

  Reed, Stephanie Collins ^a   Evans, Suzette M ^a   Bedi, Gillinder ^a   Rubin, Eric ^a   Foltin, Richard W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Cardiovascular effects; Cocaine; Humans; Menstrual cycle; Progesterone; Self administration; Subjective effects; Women

Indexed keywords

COCAINE; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; COST CONTROL; DRUG EFFICACY; DRUG SELF ADMINISTRATION; FEMALE; FOLLICULAR PHASE; HOSPITAL PATIENT; HUMAN; HUMAN EXPERIMENT; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; COCAINE; COCAINE-RELATED DISORDERS; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HORMONES; HUMANS; PROGESTERONE; SELF ADMINISTRATION; SMOKING;

EID: 79851512395     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2010.12.009     Document Type: Article

References (84)

1. Anker J.J., Carroll M.E. The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research. Neurosci. Biobehav. Rev. 2010, 35:315-333.
2. Anker J.J., Carroll M.E. Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats. Drug Alcohol Depend. 2010, 107:264-267.
3. Anker J.J., Larson E.B., Gliddon L.A., Carroll M.E. Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats. Exp. Clin. Psychopharmacol 2007, 15:472-480.
4. Anker J.J., Holtz N.A., Zlebnik N., Carroll M.E. Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats. Psychopharmacology 2009, 203:63-72.
5. Becker J.B., Hu M. Sex differences in drug abuse. Front. Neuroendocrinol. 2008, 29:36-47.
6. Becker J.B., Molenda H., Hummer D.L. Gender differences in the behavioral responses to cocaine and amphetamine: implications for mechanisms mediating gender differences in drug abuse. Ann. N. Y. Acad. Sci. 2001, 937:172-187.
7. Carroll M.E., Anker J.J. Sex differences and ovarian hormones in animal models of drug dependence. Horm. Behav. 2010, 58:44-56.
8. Carroll M.E., Morgan A.D., Lynch W.J., Campbell U.C., Dess N.K. Intravenous cocaine and heroin self-administration in rats selectively bred for differential saccharin intake: phenotype and sex differences. Psychopharmacology 2002, 161:304-313.
9. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., Cosgrove K.P. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 2004, 25:273-279.
10. Carroll K.M., Fenton L.R., Ball S.A., Nich C., Frankforter T.L., Shi J., Rounsaville B.J. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch. Gen. Psychiatry 2004, 61:264-272.
11. Childs E., Van Dam N.T., De Wit H. Effects of acute progesterone administration upon responses to acute psychosocial stress in men. Exp. Clin. Psychopharmacol. 2010, 18:78-86.
12. Collins S.L., Evans S.M., Foltin R.W., Haney M. Intranasal cocaine in humans: effects of sex and menstrual cycle. Pharmacol. Biochem. Behav. 2007, 86:117-124.
13. Comer S.D., Ashworth J.B., Foltin R.W., Johanson C.E., Zacny J.P., Walsh S.L. The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend. 2008, 96:1-15.
14. De Lignières B. Oral micronized progesterone. Clin. Ther. 1999, 21:41-60.
15. Donny E.C., Bigelow G.E., Walsh S.L. Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement. Drug Alcohol Depend. 2003, 69:289-301.
16. Evans S.M. The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp. Clin. Psychopharmacology 2007, 29:1889-1900.
17. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31:659-674.
18. Evans S.M., Foltin R.W. Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates?. Horm. Behav. 2010, 58:13-21.
19. Evans S.M., Levin F.R., Fischman M.W., Foltin R.W. Smoked cocaine self-administration in females and voucher incentives for abstinence. J. Subst. Abuse 1998, 10:143-162.
20. Evans S.M., Haney M., Levin F.R., Foltin R.W., Fischman M.W. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam. Neuropsychopharm 1998, 19:499-516.
21. Evans S.M., Haney M., Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 2002, 159:397-406.
22. Feltenstein M.W., See R.E. Plasma progesterone levels and cocaine-seeking in freely cycling female rats across the estrous cycle. Drug Alcohol Depend. 2007, 89:183-189.
23. Feltenstein M.W., Byrd E.A., Henderson A.R., See R.E. Attenuation of cocaine-seeking by progesterone treatment in female rats. Psychoneuroendocrinology 2009, 34:343-352.
24. Festa E.D., Quiñones-Jenab V. Gonadal hormones provide the biological basis for sex differences in behavioral responses to cocaine. Horm. Behav. 2004, 46:509-519.
25. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV Axis I disorders - Patient Edition (SCID-I/P, version 2.0) 1995, Biometrics Research Department. New York State Psychiatric Institute, New York, NY.
26. Foltin R.W., Haney M. Conditioned effects of environmental stimuli paired with smoked cocaine in humans. Psychopharmacology 2000, 149:24-33.
27. Foltin R.W., Fischman M.W., Nestadt G., Stromberger H., Cornell E.E., Pearlson G.D. Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend. 1990, 26:145-154.
28. Frye C.A. Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacol. Biochem. Behav. 2007, 86:209-219.
29. Haney M. Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls. Addict. Biol. 2009, 14:9-21.
30. Haney M., Spealman R. Controversies in translational research: drug self administration. Psychopharmacology 2008, 199:403-419.
31. Haney M., Foltin R.W., Fischman M.W. Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology 1998, 137:15-24.
32. Haney M., Hart C., Collins E.D., Foltin R.W. Smoked cocaine discrimination in humans: effects of gabapentin. Drug Alcohol Depend. 2005, 80:53-61.
33. Haney M., Hart C.L., Foltin R.W. Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology 2006, 31:1814-1821.
34. Hart C., Haney M., Collins E.D., Rubin E., Foltin R.W. Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend. 2007, 86:274-277.
35. Hart C.L., Haney M., Foltin R.W., Fischman M.W. Alternative reinforcers differentially modify cocaine self-administration by humans. Behav. Pharmacol. 2000, 11:87-91.
36. Hart C.L., Haney M., Vosburg S.K., Rubin E., Foltin R.W. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 2008, 33:761-768.
37. Hart C., Ward A.S., Collins E.D., Haney M., Foltin R.W. Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend. 2004, 73:279-287.
38. Hecht G.S., Spear N.E., Spear L.P. Changes in progressive ratio responding for intravenous cocaine throughout the reproductive process in female rats. Dev. Psychobiol. 1999, 35:136-145.
39. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Donham R., Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch. Gen. Psychiatry 1994, 51:568-576.
40. Highfield D.A., Mean A.N., Grimm J.W., Rocha B.A., Shaham Y. Reinstatement of cocaine seeking in 129X1/SvJ mice: effects of cocaine priming, cocaine cues and food deprivation. Psychopharmacology 2002, 161:417-424.
41. Hu M., Crombag H.S., Robinson T.E., Becker J.B. Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology 2004, 29:81-85.
42. Hudson A., Stamp J.A. Ovarian hormones and propensity to drug relapse: a review. Neurosci. Biobehav. Rev. 2011, 35:427-436.
43. Hyman S.M., Paliwal P., Chaplin T.M., Mazure, Rounsaville B.J., Sinha R. Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Depend. 2008, 92:208-216.
44. Jackson L.R., Robinson T.E., Becker J.B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 2006, 31:129-138.
45. Larson E.B., Anker J.J., Gliddon L.A., Fons K.S., Carroll M.E. Effects of estrogen and progesterone on the escalation of cocaine self-administration in female rats during extended access. Exp. Clin. Psychopharmacol. 2007, 15:461-471.
46. Leri F., Stewart J. Drug-induced reinstatement to heroin and cocaine seeking: a rodent model of relapse in polydrug use. Exp. Clin. Psychopharmacol. 2001, 9:297-306.
47. Leyton M. Conditioned and sensitized responses to stimulant drugs in humans. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1601-1613.
48. Lukas S.E., Sholar M., Lundahl L.H., Lamas X., Kouri E., Wines J.D., Kragie L., Mendelson J.H. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 1996, 125:346-354.
49. Lynch W.J., Carroll M.E. Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology 1999, 144:77-82.
50. Lynch W.J., Carroll M.E. Reinstatement of cocaine self-administration in rats: sex differences. Psychopharmacology 2000, 148:196-200.
51. Lynch W.J., Arizzi M.N., Carroll M.E. Effects of sex and the estrous cycle on regulation of intravenously self-administered cocaine in rats. Psychopharmacology 2000, 152:132-139.
52. Lynch W.J., Roth M.E., Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 2002, 164:121-137.
53. Martini M.C., Lampe J.W., Slavin J.L., Kurzer M.S. Effect of the menstrual cycle on energy and nutrient intake. Am. J. Clin. Nutr. 1994, 60:895-899.
54. Maxson W.S., Hargrove J.T. Bioavailability of oral micronized progesterone. Fertil. Steril. 1985, 44:622-626.
55. Mello N.K., Mendelson J.H. Cocaine, hormones, and behavior: clinical and preclinical studies. Horm. Brain Behav. 2002, 5:665-745.
56. Mendelson J.H., Mello N.K., Sholar M.B., Siegel A.J., Kaufman M.J., Levin J.M., Renshaw P.F., Cohen B.M. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 1999, 21:294-303.
57. Nagoshi C., Kumor K.M., Muntaner C. Test-retest stability of cardiovascular and subjective responses to intravenous cocaine in humans. Br. J. Addict. 1992, 87:591-599.
58. Niyomchai T., Akhavan A., Festa E.D., Lin S.N., Lamm L., Foltz R., Quiñones-Jenab V. Estrogen and progesterone affect cocaine pharmacokinetics in female rats. Brain Res. Bull. 2006, 68:310-314.
59. O' Brien M.S., Anthony J.C. Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001. Neuropsychopharmacology 2005, 30:1006-1018.
60. Reed S.C., Haney M., Evans S.M., Vadhan N.P., Rubin E., Foltin R.W. Cardiovascular and subjective effects of repeated smoking cocaine administration in experienced cocaine users. Drug Alcohol Depend. 2009, 102:102-107.
61. Ridenour T.A., Maldonado-Molina M., Compton W.M., Spitznagel E.L., Cottler L.B. Factors associated with the transition from abuse to dependence among substance abusers: implications for a measure of addictive liability. Drug Alcohol Depend. 2005, 80:1-14.
62. Roberts D.C., Bennett S.A., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 1989, 98:408-411.
63. Robinson T.E., Browman K.E., Crombag H.S., Badiani A. Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci. Biobehav. Rev. 1998, 22:347-354.
64. Rothman R.B., Gorelick D.A., Baumann M.H., Guo X.Y., Herning R.I., Pickworth W.B., Gendron T.M., Koeppl B., Thomson L.E. Lack of evidence for context-dependent cocaine-induced sensitization in humans: preliminary studies. Pharmacol. Biochem. Behav. 1994, 49:583-588.
65. Russo S.J., Sun W.L., Minerly C., Weierstall K., Nazarian A., Festa E.D., Niyomchai T., Akhavan A., Luine V., Jenab S., Quiñones-Jenab V. Progesterone attenuates cocaine-induced conditioned place preference in female rats. Brain Res. 2008, 1189:229-235.
66. Russo S.J., Sun W.L., Minerley A.C., Weierstall K., Nazarian A., Festa E.D., Niyomchai T., Akhavan A., Jenab S., Quiñones-Jenab V. Progesterone does not affect cocaine-induced conditioned place preference or locomotor activity in male rats. Ethn. Dis. 2010, 20:S1-73-7.
67. Sayre S.L., Schmitz J.M., Stotts A.L., Averill P.M., Rhoades H.M., Grabowski J.J. Determining predictors of attrition in an outpatient substance abuse program. Am. J. Drug Alcohol Abuse 2002, 28:55-72.
68. Simon J.A., Robinson D.E., Andrews M.C., Hildebrand J.R., Rocci M.L., Blake M.E., Hodgen G.D. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil. Steril. 1993, 60:26-33.
69. Sinha R., Garcia M., Paliwal P., Kreek M.J., Rounsaville B.J. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch. Gen. Psychiatry 2006, 63:324-331.
70. Siqueland L., Crits-Christoph P., Gallop R., Barber J.P., Griffin M.L., Thase M.E., Daley D., Frank A., Gastfriend D.R., Blaine J., Connolly M.B., Gladis M. Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am. J. Addict. 2002, 11:24-40.
71. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P.R., Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp. Clin. Psychopharmacol. 1999, 7:274-283.
72. Sofuoglu M., Babb D.A., Hatsukami D.K. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol. Biochem. Behav. 2002, 72:431-435.
73. Sofuoglu M., Mitchell E., Kosten T.R. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol. Biochem. Behav. 2004, 78:699-705.
74. Sofuoglu M., Poling J., Gonzalez G., Gonsai K., Oliveto A., Kosten T.R. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Exp. Clin. Psychopharmacol. 2007, 15:453-460.
75. Stewart J. Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-administration. Prog. Neuropsychopharmacol. Biol. Psychiatry 1983, 7:591-597.
76. Stoops W.W., Lile J.A., Rush C.R. Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacol. Biochem. Behav. 2010, 95:187-191.
77. Substance Abuse and Mental Health Services Administration Office of Applied Studies 2009, National Survey on Drug Use and Health, (NSDUH, Rockville, MD.
78. Substance Abuse Mental Health Services Administration Office of Applied Studies 2008, Treatment Episode Data Set (TEDS, Rockville, MD.
79. Terner J.M., De Wit H. Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend. 2006, 84:1-13.
80. Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. J. Addict. Dis. 2010, 29:127-138.
81. Volkow D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., Jayne M., Ma Y., Wong C. Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage 2008, 39:1266-1273.
82. Vosburg S.K., Haney M., Rubin E., Foltin R.W. Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance. Drug Alcohol Depend. 2010, 110:144-150.
83. Walsh S.L., Geter-Douglas B., Strain E.C., Bigelow G.E. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J. Pharmacol. Exp. Ther. 2001, 299:147-158.
84. Wu L.T., Pan J.J., Blazer D.G., Tai B., Stitzer M.L., Woody G.E. Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study. J. Subst. Abuse Treat. 2010, 38:S70-S79.